US FDA strengthens renal warnings for diabetes products

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1607卷 / 1期

关键词：

D O I：

10.1007/s40278-016-18580-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：6 / 6

相关论文

共 50 条

[1] FDA strengthens warnings for fluoroquinolones
Reactions Weekly, 2018, 1711 (1) : 1 - 1
[2] FDA strengthens valproate warnings for pregnant women
Reactions Weekly, 2013, 1452 (1) : 2 - 2
[3] US FDA to enhance warnings on antidepressant labelling
Reactions Weekly, 2004, 1020 (1) : 2 - 2
[4] US FDA strengthens isotretinoin risk management programme
Reactions Weekly, 2005, 1065 (1) : 3 - 3
[5] US FDA 2009 drug safety warnings analysed
Reactions Weekly, 2012, 1388 (1) : 4 - 4
[6] US FDA committed to timely public warnings of recalls
Reactions Weekly, 2018, 1687 (1) : 3 - 3
[7] US FDA issues warnings to homoeopathic medicine makers
Reactions Weekly, 2019, 1754 (1) : 4 - 4
[8] FROM THE FDA - WARNINGS ISSUED ABOUT PRACTICES, PRODUCTS
NIGHTINGALE, S
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (11): : 1428 - 1428
[9] EC strengthens warnings on tilmicosin
不详
VETERINARY RECORD, 2006, 159 (02) : 31 - 31
[10] FDA issues warnings for Pharmakon's sterile drug products
Reactions Weekly, 2016, 1599 (1) : 2 - 2

← 1 2 3 4 5 →